WVU020924: Phase I/II study of leflunomide in combination with decitabine for treatment of relapsed or refractory myelodysplastic syndromes
- Title
- Phase I/II study of leflunomide in combination with decitabine for treatment of relapsed or refractory myelodysplastic syndromes
- Principal Investigator
- Sdrimas, Konstantinos
- Phase
- I/II
- Age Group
- Adult
- Applicable Disease Sites
- Other Cancers
- Other Hematopoietic
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Wheeling Hospital
- Contacts
- Abby Swiger, RN
- Research Nurse
- Phone: +1 304-293-1683
- Email: aswiger3@hsc.wvu.edu
- Maher Kali, MD
- Clinical Research Specialist-WVUCI
- Phone: +1 304-243-7045
- Email: maher.kali@wvumedicine.org